Promising early Phase 1 test results for Medicago’s COVID-19 vaccine
100% of subjects developed a promising antibody response after two doses.
Novavax trials coronavirus vaccine candidate in Australia
US company will inject 131 volunteers in first phase to test the safety of the vaccine and look for signs of its effectiveness.
Companies rush to produce cannabis-free products
They’re moving towards synthetic production of THC and other cannabinoids in a lab.